NP

Naresh Potlapalli

Active Director Director DIN 11936977
DIN 11936977 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Naresh Potlapalli

Naresh Potlapalli is a Director at Varnyle Health Care Private Limited (since 2026).

DIN 11936977
Primary Designation Director
First Appointment 09 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Varnyle Health Care Private Limited U46497TS2026PTC222481
Director09 Sep 20262026Active

Board colleagues of Naresh Potlapalli

NameDINCompanyDesignation
Mankena Sreepath KumarVarnyle Health Care Private LimitedManager/Secretary/Auth Rep
Santhosh Kumar Potlapally11936976Varnyle Health Care Private LimitedDirector/Designated Partner

Directorship timeline

Open interactive timeline →
Varnyle Health Care Private Limited
Premium access

Shareholding and investment profile for Naresh Potlapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Potlapalli

Naresh Potlapalli currently holds 1 directorship: Varnyle Health Care Private Limited (Director, since 09 Sep 2026).

Naresh Potlapalli was first appointed on 09 Sep 2026 as Director at Varnyle Health Care Private Limited.

The current boards of Naresh Potlapalli's companies include Mankena Sreepath Kumar (Varnyle Health Care Private Limited), Santhosh Kumar Potlapally (Varnyle Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available